Biophysics Seminar

GC4419 is a normal tissue radioprotector that also enhances the anti-tumor effects of high dose per fraction radiation and immune therapy

by Dr Anthony J. Davis (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA) , Dr Michael Dean Story (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA)

Europe/Berlin
Lecture hall, Theory SB3 3.170a (GSI Helmholtzzentrum für Schwerionenforschung GmbH)

Lecture hall, Theory SB3 3.170a

GSI Helmholtzzentrum für Schwerionenforschung GmbH

Planckstraße 1, 64291 Darmstadt, Germany
Slides